Keywords: Salix Pharma, Crofelemer, Diarrhea, HIV patients, PDUFA date delay, USA, FDA

FDA action on Salix' crofelemer delayed until 2013

Article | 05 September 2012

Print This

There was disappointing news for Salix Pharmaceuticals (Nasdaq: SLXP) with the Food and Drug Administration advising the company that its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in